# INTERVENCION Trial

> **NCT02373163** · PHASE4 · COMPLETED · sponsor: **Prevencion** · enrollment: 166 (actual)

## Conditions studied

- Blood Pressure, High

## Interventions

- **DRUG:** Hydrochlorothiazide
- **DRUG:** Amlodipine
- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT02373163
- **Lead sponsor:** Prevencion
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-01
- **Primary completion:** 2016-03-01
- **Final completion:** 2016-06-01
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02373163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02373163, "INTERVENCION Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02373163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*